COMP <GO>
CRBG vs MS // 10Y YIELD & FRED MACRO BETA
Corebridge Financial Inc. (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CRBG 4
— MS 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: CRBG
LAST: $34.81 (-1.36%) • MKT CAP: $15.73B
macro-sensitivity
1.14
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
macro-sensitivity
1.04
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRBG VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRBG | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -0.30% | 3.00% | -3.30 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 31.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.56% | -7.25% | +14.81 | CRBG | /fcf-yield <GO> |
| Operating Margin | -2.40% | 24.60% | -27.00 | MS | /operating-margins <GO> |
| Net Profit Margin | -2.00% | 20.20% | -22.20 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | -1.20% | 5.50% | -6.70 | MS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.25% | 2.21% | +1.04 | CRBG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.46 | -0.01 | MS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 7.00% | +0.40 | MS | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.1 | 43.3 | +8.78 | CRBG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.14 | 1.04 | +0.10 | CRBG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.0x | 16.5x | +2.50 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.73B | $298.41B | -$282.68B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRBG REV | MS REV | CRBG GROSS % | MS GROSS % | CRBG FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.48B | $0 | 44.0% | — | $1.19B | -$17.89B |
| FY 2024 | $18.71B | $0 | 44.0% | — | $1.31B | $1.36B |
| FY 2023 | $18.80B | $0 | 44.0% | — | $2.51B | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRBG // BETA 1.14
MS // BETA 1.04